Unfortunately, 30-40% of CRT treated patients are reported to have either no response or worsened HF. Limitations of patient selection technique and definition of CRT response likely contribute to high non-response rates. [12] [13] [14] In this issue of the Journal of Nuclear Medicine, Badwhar et al present a novel and effective approach to determining which patients most likely benefit from CRT using new measures of both intra-LV and inter-ventricular dyssynchrony by planar equilibrium radionuclide angiography (ERNA). [15] This cardiac blood pool based approach utilizes the first harmonic curve fit by phase and amplitude for each ERNA pixel as a surrogate for the timing and magnitude of regional contraction relative to the ECG R wave gating signal.
In a previous report [16] , ERNA derived phase angle (Ø), and amplitude quantitate regional contraction timing and magnitude and are the basis for synchrony and entropy parameters. Synchrony is the vector sum of all amplitudes based on the angular distribution of Ø divided by the scalar sum of the length of all vectors, and Entropy measures the disorder in the region of interest. These parameters were previously reported to be superior to SD of Ø to distinguish hearts with normal, aneurysmal, diffuse dysfunction and severe regional dysfunction. [16] In the current study, ERNA measurements of LV synchrony (LVS) and interventricular synchrony (IVS, the difference between mean LVS and RV synchrony), were strongly predictive of response to CRT of NYHA symptom class. Lower baseline LVS and higher baseline IVS predicted greater response to CRT with larger improvements in NYHA functional class. These findings are particularly relevant in patients with QRS duration of 120-150 msec with LBBB and those with QRS duration >=150 msec with non-LBBB morphology, in whom CRT is less strongly recommended.
Badwhar's planar ERNA approach has several advantages compared with other imaging techniques used to evaluate dyssynchrony and predict CRT response. In the past, numerous echocardiographic approaches have attempted to identify patients most likely to benefit from CRT. A major weakness of echocardiographic techniques is the lack of reproducibility. While echocardiographic techniques assess dyssynchrony in either longitudinal or circumferential direction, the lack of a composite 3D echocardiographic assessment of ventricular dyssynchrony limits its effectiveness.
by on November 7, 2017. For personal use only. jnm.snmjournals.org Downloaded from Although 3D echocardiography reportedly enhances accuracy and reproducibility of the assessment of LV volumes and EF as well as assessment of myocardial dyssynchrony of the cardiac ultrasound approach [17, 18] , its use in contemporary practice remains limited. Thus, an effective echocardiographic strategy for predicting CRT response remains elusive, and the American Society of Echocardiography recommends strongly against withholding CRT based on lack of echocardiographic evidence of dyssynchrony.
[19] Cardiac MRI is another strategy to evaluate dyssynchrony; however, widespread use is limited by cost, access issues, and incompatibility of many pacemaker and ICD devices with MRI. [20] By contrast, radionuclide imaging techniques such as planar ERNA can be safely performed in patients with pacemaker and ICD devices, and are highly reproducible, semi-automated with limited operator intervention.
Radionuclide-based dyssynchrony assessment utilizing phase analysis of gated SPECT myocardial perfusion image (MPI) data [21] has gained widespread recognition since its initial report of clinical utility for of acute CRT response predictive of long term HF outcome [22, 23] . Both blood pool and MPI techniques offer the advantage of excellent statistical sampling of up to hundreds of beats for quantitative assessment of dyssynchrony. Distinct from the ERNA blood pool based approach utilizing the first harmonic curve fit by phase and amplitude for each ERNA pixel as a surrogate for the timing and magnitude of regional contraction relative to the ECG R wave gating signal, as reported in this issue of the Journal by Badwahr, ECG-gated SPECT MPI assessment of dyssynchrony relies on quantifying regional temporal differences in myocardial thickening of 600 myocardial voxels of myocardial count density during the summated cardiac cycle [21, 22] . With this approach, acute change in synchrony preand post-CRT with a single injection technique with Tc-99m sestamibi has been prospectively studied and the highly predictive markers of improved short-term clinical outcomes include presence of baseline dyssynchrony, scar burden of < 40% and concordance of LV lead with the site of latest activation. [22] The presence of baseline dyssynchrony on gated SPECT as a predictor of CRT response is similar to the predictive value of low LVS by planar ERNA noted in the current study. We now understand assessment of dyssynchrony alone as a predictor of CRT response patients with medically refractory HF will be futile, as evidenced by Echo-CRT. [24] In addition to dyssynchrony, the major predictors of CRT response include scar burden and LV lead concordance with the site of latest activation. [25, 26] The lack of assessment of these important determinants of CRT response from an ERNA based approach appears disadvantageous. However, a limitation SPECT MPI based techniques for prediction of HF response to CRT includes attenuation and perfusion abnormalities that could result in under sampling of the myocardium, especially in the basal segments. The lack of dependency on geometric boundaries and the greater temporal resolution inherent to ERNA are advantages compared to MPI techniques for assessing dyssynchrony, especially interventricular dyssynchrony which is poorly assessed by SPECT due to low techniques has the potential to prevent or limit futile CRT device implantations, expand access to CRT to those most likely to benefit, and improve the clinical and cost effectiveness of CRT for medically and surgically refractory heart failure.
